18.93MMarket Cap-725P/E (TTM)
2.2400High1.9500Low276.53KVolume2.1600Open2.2301Pre Close561.87KTurnover5.77%Turnover RatioLossP/E (Static)9.47MShares4.588052wk High-0.64P/B9.59MFloat Cap1.490052wk Low--Dividend TTM4.79MShs Float143.4487Historical High--Div YieldTTM13.00%Amplitude1.4900Historical Low2.0310Avg Price1Lot Size
Trinity Biotech Stock Forum
and Raises Guidance For 2024 TrinScreen HIV Sales
DUBLIN, Ireland (May 13, 2024)…. Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received substantial additional orders for TrinScreen HIV, bringing total orders received to date for supply in 2024 to ap...
Benzinga· 4 mins ago
Moomoo 24/7· 2 mins ago
The company said this outlook is predicated solely on growth from the existing businesses including haemoglobin testing and HIV, and planned improvements to operating margins, with no contribution from the recently acquired biosensor business.
No comment yet